Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2838)
|
Core Tip (2050)
|
Full Article (HTML) (58907)
|
Figures (1-9) (1804)
|
Full Article (PDF)-576K (2679)
|
Peer-Review Report-178K (535)
|
Answering Reviewers-107K (517)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (12)
|
Total Visits (74443)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms
World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (2098)
|
Core Tip (1820)
|
Full Article (HTML) (10840)
|
Figures (1-10) (751)
|
Tables (1-6) (626)
|
Full Article (PDF)-3685K (1122)
|
Peer-Review Report-98K (520)
|
Answering Reviewers-50K (426)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (21850)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (2062)
|
Core Tip (1737)
|
Full Article (HTML) (9181)
|
Figures (1-6) (686)
|
Tables (1-2) (463)
|
Full Article (PDF)-1438K (869)
|
Peer-Review Report-192K (337)
|
Answering Reviewers-63K (365)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (19436)
|
Similar Articles (35)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
